|
EP2341059A1
(en)
|
2005-10-12 |
2011-07-06 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
EA200901249A1
(ru)
*
|
2007-03-16 |
2010-04-30 |
Юниверсити Оф Флорида Ресерч Фаундэйшн, Инк. |
Ингибиторы связывания протеинкиназ
|
|
EP2349271A2
(en)
*
|
2008-10-06 |
2011-08-03 |
Idera Pharmaceuticals, Inc. |
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
|
|
KR101881596B1
(ko)
|
2008-12-02 |
2018-07-24 |
웨이브 라이프 사이언시스 재팬 인코포레이티드 |
인 원자 변형된 핵산의 합성 방법
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
EP2391718A2
(en)
*
|
2009-01-30 |
2011-12-07 |
Idera Pharmaceuticals, Inc. |
Novel synthetic agonists of tlr9
|
|
AU2010229835B2
(en)
|
2009-03-25 |
2015-01-15 |
The Board Of Regents Of The University Of Texas System |
Compositions for stimulation of mammalian innate immune resistance to pathogens
|
|
RU2612521C2
(ru)
|
2009-07-06 |
2017-03-09 |
Онтории, Инк. |
Новые пролекарства нуклеиновых кислот и способы их применения
|
|
WO2011005942A2
(en)
*
|
2009-07-08 |
2011-01-13 |
Idera Pharmaceuticals, Inc. |
Oligonucleotide-based compounds as inhibitors of toll-like receptors
|
|
US9562014B2
(en)
|
2009-07-16 |
2017-02-07 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
NO2453895T3
(OSRAM)
*
|
2009-07-16 |
2018-10-20 |
|
|
|
US10363251B2
(en)
|
2009-07-16 |
2019-07-30 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
EP2470656B1
(en)
*
|
2009-08-27 |
2015-05-06 |
Idera Pharmaceuticals, Inc. |
Composition for inhibiting gene expression and uses thereof
|
|
WO2011041311A2
(en)
*
|
2009-09-29 |
2011-04-07 |
Yale University |
Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
|
|
JP2011084517A
(ja)
*
|
2009-10-15 |
2011-04-28 |
Koreaki Taniguchi |
核酸により活性化される自然免疫応答の抑制剤及びスクリーニング方法
|
|
EP2550360B1
(en)
*
|
2010-03-24 |
2017-08-30 |
Mirrx Therapeutics A/s |
Bivalent antisense oligonucleotides
|
|
GB201014026D0
(en)
*
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
|
JP5686814B2
(ja)
|
2010-09-17 |
2015-03-18 |
独立行政法人科学技術振興機構 |
Ｈｍｇｂタンパクによって仲介される免疫応答の活性化の抑制剤及びスクリーニング方法
|
|
JP5868324B2
(ja)
|
2010-09-24 |
2016-02-24 |
株式会社Wave Life Sciences Japan |
不斉補助基
|
|
US8486908B2
(en)
|
2010-11-19 |
2013-07-16 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
GB201022049D0
(en)
*
|
2010-12-29 |
2011-02-02 |
Imp Innovations Ltd |
Methods
|
|
US8877722B2
(en)
*
|
2011-03-25 |
2014-11-04 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting gene expression and uses thereof
|
|
WO2013106068A2
(en)
*
|
2011-05-16 |
2013-07-18 |
Haus Bioceuticals, Inc. |
Therapeutic compositions of specified herbal formulations and uses thereof
|
|
BR112014001244A2
(pt)
|
2011-07-19 |
2017-02-21 |
Wave Life Sciences Pte Ltd |
métodos para a síntese de ácidos nucléicos funcionalizados
|
|
EP2756080B1
(en)
|
2011-09-14 |
2019-02-20 |
Translate Bio MA, Inc. |
Multimeric oligonucleotide compounds
|
|
BR112015000723A2
(pt)
*
|
2012-07-13 |
2017-06-27 |
Shin Nippon Biomedical Laboratories Ltd |
adjuvante de ácido nucléico quiral
|
|
CN112007045A
(zh)
|
2012-07-13 |
2020-12-01 |
波涛生命科学有限公司 |
手性控制
|
|
ES2862073T3
(es)
|
2012-07-13 |
2021-10-06 |
Wave Life Sciences Ltd |
Grupo auxiliar asimétrico
|
|
WO2014043544A1
(en)
|
2012-09-14 |
2014-03-20 |
Rana Therapeutics, Inc. |
Multimeric oligonucleotide compounds
|
|
CN103845731B
(zh)
*
|
2012-12-05 |
2015-12-02 |
复旦大学 |
抗st2/il-1r4抗体在制备防治瘙痒药物中的应用
|
|
CN103845730B
(zh)
*
|
2012-12-05 |
2015-12-09 |
复旦大学 |
抗st2/il-1 r4抗体在制备镇痛药物中的用途
|
|
EP2943251B1
(en)
*
|
2013-01-08 |
2018-10-10 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
CN103961697A
(zh)
*
|
2013-02-05 |
2014-08-06 |
日东电工株式会社 |
粘膜给予用疫苗组合物
|
|
GB2514591A
(en)
*
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
EP3095460A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
EP3095459A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
|
|
CN113278617A
(zh)
|
2014-01-16 |
2021-08-20 |
波涛生命科学有限公司 |
手性设计
|
|
CA2953216C
(en)
|
2014-06-04 |
2020-12-22 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
EP3220895B1
(en)
|
2014-11-21 |
2022-08-31 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
SK500652015A3
(sk)
|
2015-10-15 |
2017-05-03 |
Ústav Polymérov Sav |
Spôsob úpravy funkčného stavu ľubovoľnej mRNA umožňujúci jej selektívne a špecifické rozpoznanie
|
|
CN105541947A
(zh)
*
|
2016-01-11 |
2016-05-04 |
中国人民解放军第三军医大学第一附属医院 |
拮抗tlr7/8及tlr9活化的药物分子及用途
|
|
CN105597079A
(zh)
*
|
2016-01-11 |
2016-05-25 |
中国人民解放军第三军医大学第一附属医院 |
用于治疗银屑病的药物
|
|
KR20190017872A
(ko)
|
2016-06-08 |
2019-02-20 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
염증 및 면역 반응 유도를 감소시키는 조작된 바이러스 벡터
|
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
|
EP3538513A1
(en)
|
2016-11-11 |
2019-09-18 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
US10947545B2
(en)
*
|
2016-11-23 |
2021-03-16 |
Berlin Cures GmbH |
Aptamers for use in inhibition and/or suppression of TLR9 activation
|
|
WO2018209270A1
(en)
|
2017-05-11 |
2018-11-15 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (snas)
|
|
US11473145B2
(en)
|
2017-07-27 |
2022-10-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for determining whether a patient suffering from rhabdomyolysis achieves a response with a TLR9 antagonist
|
|
KR20200085812A
(ko)
|
2017-11-08 |
2020-07-15 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
바이러스 벡터-유도된 염증 반응을 억제하기 위한 조성물 및 방법
|
|
CN112533607B
(zh)
|
2018-05-25 |
2025-01-07 |
普利缪尼治疗学股份有限公司 |
Tlr7激动剂
|
|
TWI867097B
(zh)
|
2019-11-26 |
2024-12-21 |
美商普姆治療公司 |
Tlr7促效劑
|
|
CN114981436A
(zh)
*
|
2020-01-10 |
2022-08-30 |
Sbi生物技术有限公司 |
新tlr9激动剂
|